Induced Pluripotent Stem Cells: Developmental Biology to Regenerative Medicine

Overview

Journal Nat Rev Cardiol

Specialty Cardiology & Vascular Diseases

Date 2010 Oct 20

PMID 20956984

Citations 51

Authors

Timothy J Nelson

Almudena Martinez-Fernandez

Andre Terzic

Affiliations

Soon will be listed here.

Abstract

Nuclear reprogramming of somatic cells with ectopic stemness factors to bioengineer pluripotent autologous stem cells signals a new era in regenerative medicine. The study of developmental biology has provided a roadmap for cardiac differentiation from embryonic tissue formation to adult heart muscle rejuvenation. Understanding the molecular mechanisms of stem-cell-derived cardiogenesis enables the reproducible generation, isolation, and monitoring of progenitors that have the capacity to recapitulate embryogenesis and differentiate into mature cardiac tissue. With the advent of induced pluripotent stem (iPS) cell technology, patient-specific stem cells provide a reference point to systematically decipher cardiogenic differentiation through discrete stages of development. Interrogation of iPS cells and their progeny from selected cohorts of patients is an innovative approach towards uncovering the molecular mechanisms of disease. Thus, the principles of cardiogenesis can now be applied to regenerative medicine in order to optimize personalized therapeutics, diagnostics, and discovery-based science for the development of novel clinical applications.

Citing Articles

Reporter Alleles in hiPSCs: Visual Cues on Development and Disease.

Cotta G, Teixeira Dos Santos R, Costa G, Lacerda S Int J Mol Sci. 2024; 25(20).

PMID: 39456792 PMC: 11507014. DOI: 10.3390/ijms252011009.

Engineering a conduction-consistent cardiac patch with rGO/PLCL electrospun nanofibrous membranes and human iPSC-derived cardiomyocytes.

Tan Y, Chen Y, Lu T, Witman N, Yan B, Gong Y Front Bioeng Biotechnol. 2023; 11:1094397.

PMID: 36845196 PMC: 9944832. DOI: 10.3389/fbioe.2023.1094397.

Research Advances of Injectable Functional Hydrogel Materials in the Treatment of Myocardial Infarction.

Hu W, Yang C, Guo X, Wu Y, Loh X, Li Z Gels. 2022; 8(7).

PMID: 35877508 PMC: 9316750. DOI: 10.3390/gels8070423.

iPSC Therapy for Myocardial Infarction in Large Animal Models: Land of Hope and Dreams.

Martinez-Falguera D, Iborra-Egea O, Galvez-Monton C Biomedicines. 2021; 9(12).

PMID: 34944652 PMC: 8698445. DOI: 10.3390/biomedicines9121836.

The use of induced pluripotent stem cells in domestic animals: a narrative review.

Scarfone R, Pena S, Russell K, Betts D, Koch T BMC Vet Res. 2020; 16(1):477.

PMID: 33292200 PMC: 7722595. DOI: 10.1186/s12917-020-02696-7.

References

Olson E . A decade of discoveries in cardiac biology. Nat Med. 2004; 10(5):467-74. DOI: 10.1038/nm0504-467. View

Li H, Collado M, Villasante A, Strati K, Ortega S, Canamero M . The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature. 2009; 460(7259):1136-9. PMC: 3578184. DOI: 10.1038/nature08290. View

Alper J . Geron gets green light for human trial of ES cell-derived product. Nat Biotechnol. 2009; 27(3):213-4. DOI: 10.1038/nbt0309-213a. View

Ishiwata T, Nakazawa M, Pu W, Tevosian S, Izumo S . Developmental changes in ventricular diastolic function correlate with changes in ventricular myoarchitecture in normal mouse embryos. Circ Res. 2003; 93(9):857-65. DOI: 10.1161/01.RES.0000100389.57520.1A. View

Woltjen K, Michael I, Mohseni P, Desai R, Mileikovsky M, Hamalainen R . piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 2009; 458(7239):766-70. PMC: 3758996. DOI: 10.1038/nature07863. View

Campbell K, McWhir J, Ritchie W, Wilmut I . Sheep cloned by nuclear transfer from a cultured cell line. Nature. 1996; 380(6569):64-6. DOI: 10.1038/380064a0. View

Padin-Iruegas M, Misao Y, Davis M, Segers V, Esposito G, Tokunou T . Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation. 2009; 120(10):876-87. PMC: 2913250. DOI: 10.1161/CIRCULATIONAHA.109.852285. View

Yang L, Soonpaa M, Adler E, Roepke T, Kattman S, Kennedy M . Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature. 2008; 453(7194):524-8. DOI: 10.1038/nature06894. View

Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, Matsuoka S . Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation. 2008; 118(5):498-506. DOI: 10.1161/CIRCULATIONAHA.108.769562. View

10.

Laflamme M, Murry C . Regenerating the heart. Nat Biotechnol. 2005; 23(7):845-56. DOI: 10.1038/nbt1117. View

11.

Marion R, Strati K, Li H, Murga M, Blanco R, Ortega S . A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature. 2009; 460(7259):1149-53. PMC: 3624089. DOI: 10.1038/nature08287. View

12.

Terzic A, Nelson T . Regenerative medicine advancing health care 2020. J Am Coll Cardiol. 2010; 55(20):2254-7. DOI: 10.1016/j.jacc.2009.12.050. View

13.

Hotta A, Ellis J . Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states. J Cell Biochem. 2008; 105(4):940-8. DOI: 10.1002/jcb.21912. View

14.

Ebert A, Yu J, Rose Jr F, Mattis V, Lorson C, Thomson J . Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. 2008; 457(7227):277-80. PMC: 2659408. DOI: 10.1038/nature07677. View

15.

Chang C, Lai Y, Pawlik K, Liu K, Sun C, Li C . Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells. 2009; 27(5):1042-9. DOI: 10.1002/stem.39. View

16.

Yamanaka S . Pluripotency and nuclear reprogramming. Philos Trans R Soc Lond B Biol Sci. 2008; 363(1500):2079-87. PMC: 2610180. DOI: 10.1098/rstb.2008.2261. View

17.

Nelson T, Behfar A, Terzic A . Stem cells: biologics for regeneration. Clin Pharmacol Ther. 2008; 84(5):620-3. DOI: 10.1038/clpt.2008.146. View

18.

Karumbayaram S, Novitch B, Patterson M, Umbach J, Richter L, Lindgren A . Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells. 2009; 27(4):806-11. PMC: 2895909. DOI: 10.1002/stem.31. View

19.

Jaenisch R, Young R . Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell. 2008; 132(4):567-82. PMC: 4142810. DOI: 10.1016/j.cell.2008.01.015. View

20.

Raya A, Rodriguez-Piza I, Guenechea G, Vassena R, Navarro S, Barrero M . Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature. 2009; 460(7251):53-9. PMC: 2720823. DOI: 10.1038/nature08129. View